iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Bartlett & CO. Wealth Management LLC

Bartlett & CO. Wealth Management LLC lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,277 shares of the financial services provider’s stock after selling 237 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,351,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of IBB. Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth $31,000. Pacifica Partners Inc. increased its stake in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 130 shares during the last quarter. Mather Group LLC. purchased a new position in shares of iShares Biotechnology ETF during the 1st quarter worth $57,000. Finally, Chris Bulman Inc acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $64,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $145.91 on Friday. The company has a 50-day moving average price of $145.65 and a 200 day moving average price of $139.69. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.